Publications by authors named "Yeting Cui"

Claim this Profile
R
RBM7 suppresses mitochondrial dysfunction and ferroptosis by destabilizing FBXL16 mRNA to enhance Temozolomide resistance in glioblastoma.
Nan Liu, YeTing Cui, Juan Li, SuMei Li, YanYang Tu

Mol Genet Genomics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fibroblast-specific gene signature as a therapeutic target for glioblastoma developed based on the characteristics of tumor microenvironment.
Nan Liu, Mingyue Zhao, Yeting Cui, Jiaxuan Zhao, Yanyang Tu

Eur J Med Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
shRNA-based PD-1 suppression preserves memory phenotype and function of CD19-targeted CAR-T cell.
Jiaxuan Zhao, Han Wu, Zhe Sun, Yeting Cui, Nan Liu

Transl Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of the Function and Expression of EpCAM.
Di Xiao, Mingrui Xiong, Xin Wang, Mengqing Lyu, Hanxiang Sun, Yeting Cui

Biomedicines· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cell deficiency promotes the initiation and progression of lung cancer.
Han Wu, Chen Chen, Lixing Gu, Jiapeng Li, Yunqiang Yue, Yeting Cui

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Expression of EpCAM in Primary and Metastatic Lung Cancer Is Controlled by Both Genetic and Epigenetic Mechanisms.
Yeting Cui, Jiapeng Li, Xiyu Liu, Lixing Gu, Mengqing Lyu

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis